Human Microbiome Based Drugs And Diagnostics Market Size And Share

  • Report Code : TIPRE00016877
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2025 年至 2031 年基于人类微生物组的药物和诊断市场规模、份额及预测

Buy Now

Human Microbiome Based Drugs and Diagnostics Market Report Human Microbiome Based Drugs and Diagnostics Market Scope and Analysis Human Microbiome Based Drugs and Diagnostics Market Size and Share

Human Microbiome Based Drugs and Diagnostics Market Report Analysis

Human Microbiome Based Drugs and Diagnostics Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Second Genome Inc
  • Enterome Bioscience
  • Yakult
  • DuPont
  • Vedanta BioSciences
  • Metabiomics Corporation
  • ViThera Pharmaceuticals
  • MicroBiome Therapeutics LLC
  • Merck

Regional Overview

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

By 产品
  • 食品
  • 益生菌
  • 益生元
  • 医用食品
  • 诊断设备
  • 药物
  • 其他益生菌补充剂
By 应用
  • 治疗
  • 诊断
By 疾病
  • 急性腹泻
  • 肥胖
  • 糖尿病
  • 自身免疫性疾病
  • 癌症
  • 精神障碍
  • 其他疾病
By 研究支出, 产品类型
  • 仪器
  • 消耗品